Pharmacodynamic and pharmacokinetic evaluation of SY-1425 (tamibarotene) in biomarker-selected acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients Meeting Abstract
| Authors: | Bixby, D.; Vigil, C. E.; Jurcic, J.; Cook, R.; Sekeres, M. A.; Rizzieri, D.; Cortes, J.; Redner, R.; Steensma, D.; Roboz, G.; Moyo, T.; McKeown, M.; Waters, N.; Stephens, K.; di Tomaso, E.; Roth, D. A.; Stein, E. |
| Abstract Title: | Pharmacodynamic and pharmacokinetic evaluation of SY-1425 (tamibarotene) in biomarker-selected acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx373.038 |
| Language: | English |
| ACCESSION: | WOS:000411324002220 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx373.038 |
| Notes: | Meeting Abstract: 1032P -- Appears on page 367 of the abstract book -- Source: Wos |
